These NCCN guidelines provide consensus-based recommendations for the diagnosis, staging, and treatment of soft tissue sarcomas of the extremities, superficial trunk, and head and neck. They synthesize evidence on biopsy technique, surgical margins, limb salvage, and the sequencing of radiation therapy relative to surgery. The guidelines address each disease stage and include specific radiation dosing parameters, systemic therapy options by histologic subtype, and follow-up protocols.
The 1 cm margin threshold is the most actionable number from this guideline. When margins are 1 cm or greater, local recurrence approaches zero without RT. When margins are less than 1 cm or positive, re-resection should be strongly considered before accepting adjuvant RT as a substitute for adequate surgery.
The choice between preoperative and postoperative RT is a genuine trade-off, not a simple preference. Preoperative RT risks acute wound breakdown (35% overall, 43% in lower extremity), while postoperative RT risks permanent late toxicity from a higher dose (66 Gy) and larger field. For large tumors where the treatment volume would be substantial, the NCCN panel favors preoperative RT.
Grade drives nearly every adjuvant decision in this guideline. Postoperative RT and brachytherapy both improve local control in high-grade lesions but show no significant benefit in low-grade tumors. A low-grade extremity sarcoma resected with negative margins may not require RT at all.
For the orthopedic oncology trainee: always refer suspected sarcomas to a multidisciplinary center before biopsy. An incorrectly placed biopsy tract can contaminate compartments and force a more morbid resection or amputation.
These NCCN guidelines provide consensus-based recommendations for the diagnosis, staging, and treatment of soft tissue sarcomas of the extremities, superficial trunk, and head and neck. They synthesize evidence on biopsy technique, surgical margins, limb salvage, and the sequencing of radiation therapy relative to surgery. The guidelines address each disease stage and include specific radiation dosing parameters, systemic therapy options by histologic subtype, and follow-up protocols.
The 1 cm margin threshold is the most actionable number from this guideline. When margins are 1 cm or greater, local recurrence approaches zero without RT. When margins are less than 1 cm or positive, re-resection should be strongly considered before accepting adjuvant RT as a substitute for adequate surgery.
The choice between preoperative and postoperative RT is a genuine trade-off, not a simple preference. Preoperative RT risks acute wound breakdown (35% overall, 43% in lower extremity), while postoperative RT risks permanent late toxicity from a higher dose (66 Gy) and larger field. For large tumors where the treatment volume would be substantial, the NCCN panel favors preoperative RT.
Grade drives nearly every adjuvant decision in this guideline. Postoperative RT and brachytherapy both improve local control in high-grade lesions but show no significant benefit in low-grade tumors. A low-grade extremity sarcoma resected with negative margins may not require RT at all.
For the orthopedic oncology trainee: always refer suspected sarcomas to a multidisciplinary center before biopsy. An incorrectly placed biopsy tract can contaminate compartments and force a more morbid resection or amputation.